Tutkijat / Kuopio  | Airaksinen, O(lavi) |
 | Alhava, E. |
 | Alhonen, L. |
 | Atalay, M(ustafa) |
 | Cederberg, H. |
 | Dunkel, L(eo) |
 | Eskelinen, M(atti) |
 | Giniatullin, R. |
 | Gröhn, O(lli) |
 | Harno, K. |
 | Hartikainen, J(aana). |
 | Hartikainen, J(uha). |
 | Harvima, I. |
 | Hiltunen, M(ikko) |
 | Jääskeläinen, J(uha) E. |
 | Jäkälä, P(ekka) |
 | Jänne, J. |
 | Jantunen, E(sa) |
 | Järvinen, R. |
 | Julkunen, P. |
 | Kaikkonen, M(inna) U. |
 | Kauhanen, J(ussi) |
 | Kivipelto, M(iia) |
 | Koistinaho, M. |
 | Koivisto, T(imo) |
 | Kokki, H. |
 | Könönen, M. |
 | Kosma, V(eli)-M(atti) |
 | Kröger, H. |
 | Kurl, S(udhir) |
 | Kuusisto, J(ohanna) |
 | Laakso, M(arkku) |
 | Lakka, T(imo) A. |
 | Lapinlampi, N(iina) |
 | Laukkanen, J(ari) (UEF/KSSHP) |
 | Levonen, A(nna)-L(iisa) |
 | Lindgren, A(ntti) E. |
 | Löppönen, H(eikki) |
 | Mannermaa, A. |
 | Manninen, H. |
 | Mecklin, J(ukka)-P(ekka) |
 | Moilanen, L(eena) |
 | Mönkkönen, J. |
 | Mykkänen, H. |
 | Nuutinen, J. |
 | Paajanen, H. |
 | Paananen, J. |
 | Palvimo, J.J. |
 | Pelkonen, J(ukka) |
 | Pihlajamäki, J(ussi) |
 | Pihlajamäki, M. |
 | Pitkänen, A(sla) |
 | Punnonen, K. |
 | Raatikainen K |
 | Rauramaa, R. |
 | Rissanen, T.T. |
 | Roine, R(isto) P. |
 | Ryynänen, O.P. |
 | Saarikoski, S. |
 | Schwab, U(rsula) |
 | Sivenius, J. |
 | Soininen, H(ilkka) |
 | Soininen, P(asi) |
 | Sorri, I. |
 | Stancakova, A(lena) |
 | Sulkava, R. |
 | Sund, R(eijo) |
 | Tammi, M. |
 | Tanila, H(eikki) |
 | Tiihonen, J(ari) |
 | Uusaro, A. |
 | Uusitupa, M. |
 | Vanninen, R. |
 | Vaskilampi, T. |
 | Viinamäki, H(eimo) |
 | Virtanen, M(arianna) |
 | Voutilainen, R(aimo) |
 | Voutilainen, S(ari) |
 | Wahlfors, J. |
 | Wirth, T. |
 | Wong, G. |
 | Ylä-Herttuala, S(eppo) | Scholar Chart >>
|
»My Articles
»Latest Feeds
»Popular Feeds |
| | Improved endothelialization of small-diameter ePTFE vascular grafts through growth factor therapy | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Survival After Coronary Revascularization With Paclitaxel-Coated Balloons | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Conditional power analysis of the DEBUT trial - Authors' reply | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Outcomes of lipid control in secondary prevention of coronary artery disease in Finland: A 24-month follow-up after acute coronary syndrome | Rissanen, T.T. | 51 days | save |  |  |  |  |
| CONTEMPORARY RADIATION DOSES IN INTERVENTIONAL CARDIOLOGY: A NATIONWIDE STUDY OF PATIENT SKIN DOSES IN FINLAND | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Wrist band photoplethysmography in detection of individual pulses in atrial fibrillation and algorithm-based detection of atrial fibrillation | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial | Rissanen, T.T. | 51 days | save |  |  |  |  |
| CONTEMPORARY RADIATION DOSES IN INTERVENTIONAL CARDIOLOGY: A NATIONWIDE STUDY OF PATIENT DOSES IN FINLAND | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Effectiveness of the Chest Strap Electrocardiogram to Detect Atrial Fibrillation | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Percutaneous coronary intervention with drug-coated balloon-only strategy in stable coronary artery disease and in acute coronary syndromes: An all-comers registry study | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Outcome of Cardiac Sarcoidosis Presenting With High-Grade Atrioventricular Block | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Ventricular fibrillation recorded and analysed within an area the size of a mobile phone: could it enable cardiac arrest recognition? | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Outcomes of Secondary Prevention among Coronary Heart Disease Patients in a High-Risk Region in Finland | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Adenoviral intramyocardial VEGF-DΔNΔC gene transfer increases myocardial perfusion reserve in refractory angina patients: a phase I/IIa study with 1-year follow-up | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Percutaneous Coronary Intervention of Complex Calcified Lesions With Drug-Coated Balloon After Rotational Atherectomy | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Treatment of chronic total occlusions in native coronary arteries by drug-coated balloons without stenting - A feasibility and safety study | Rissanen, T.T. | 51 days | save |  |  |  |  |
| AdVEGF-B186 and AdVEGF-DΔNΔC induce angiogenesis and increase perfusion in porcine myocardium | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Ultrasound Screening of Men with Coronary Artery Disease for Abdominal Aortic Aneurysms: A Prospective Dual Center Study | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Changes in psychopathology in schizophrenia patients starting treatment with new-generation antipsychotics: therapeutic drug monitoring in a naturalistic treatment setting | Rissanen, T.T. | 51 days | save |  |  |  |  |
| The feasibility of recognizing the heart rhythm with an automated external defibrillator from an area the size of a mobile phone | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Ultrasound imaging with bolus delivered contrast agent for the detection of angiogenesis and blood flow irregularities | Rissanen, T.T. | 51 days | save |  |  |  |  |
| HIF-1α and HIF-2α induce angiogenesis and improve muscle energy recovery | Rissanen, T.T. | 51 days | save |  |  |  |  |
| The bottleneck stent model for chronic myocardial ischemia and heart failure in pigs | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Baculovirus-mediated vascular endothelial growth factor-D(ΔNΔC) gene transfer induces angiogenesis in rabbit skeletal muscle | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Long-term VEGF-A expression promotes aberrant angiogenesis and fibrosis in skeletal muscle | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Capillary enlargement, not sprouting angiogenesis, determines beneficial therapeutic effects and side effects of angiogenic gene therapy | Rissanen, T.T. | 51 days | save |  |  |  |  |
| The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses and left ventricular function in mice | Rissanen, T.T. | 51 days | save |  |  |  |  |
| VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis | Rissanen, T.T. | 51 days | save |  |  |  |  |
| High-resolution ultrasound perfusion imaging of therapeutic angiogenesis | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Vascular endothelial growth factor-A and platelet-derived growth factor-B combination gene therapy prolongs angiogenic effects via recruitment of interstitial mononuclear cells and paracrine effects rather than improved pericyte coverage of angiogeni | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Therapeutic angiogenesis with placental growth factor improves exercise tolerance of ischaemic rabbit hindlimbs | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Current status of cardiovascular gene therapy | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Uudisverisuonten kasvattaminen-- kohti iskeemisten kudosten parempaa verenkiertoa | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Adenovirus-mediated gene transfer of human vascular endothelial growth factor-d induces transient angiogenic effects in mouse hind limb muscle | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Overexpression of VEGF-A induces neovascularization and increased vascular leakage in rabbit eye after intravitreal adenoviral gene transfer | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Gene transfer using the mature form of VEGF-D reduces neointimal thickening through nitric oxide-dependent mechanism | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Growth factor-induced therapeutic angiogenesis and arteriogenesis in the heart--gene therapy | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Gene therapy for ischemic cardiovascular diseases: some lessons learned from the first clinical trials | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Gene transfer for therapeutic vascular growth in myocardial and peripheral ischemia | Rissanen, T.T. | 51 days | save |  |  |  |  |
| HIF-VEGF-VEGFR-2, TNF-alpha and IGF pathways are upregulated in critical human skeletal muscle ischemia as studied with DNA array | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Gene transfer into rabbit arteries with adeno-associated virus and adenovirus vectors | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Oral imatinib mesylate (STI571/gleevec) improves the efficacy of local intravascular vascular endothelial growth factor-C gene transfer in reducing neointimal growth in hypercholesterolemic rabbits | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Gene expression in macrophage-rich inflammatory cell infiltrates in human atherosclerotic lesions as studied by laser microdissection and DNA array: overexpression of HMG-CoA reductase, colony stimulating factor receptors, CD11A/CD18 integrins, and i | Rissanen, T.T. | 51 days | save |  |  |  |  |
| Vascular endothelial growth factor-D expression in human atherosclerotic lesions | Rissanen, T.T. | 51 days | save |  |  |  |  |
|  report | next » | |
|